A M Svetukhin Selected Research

Fibrinogen (Factor I)

1/2001

[Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A M Svetukhin Research Topics

Disease

4	Wounds and Injuries (Trauma) 01/2008 - 01/2000
4	Infections 01/2006 - 01/2001
3	Burns 01/2002 - 01/2000
2	Osteomyelitis 01/2008 - 01/2000
2	Ischemia 01/2006 - 01/2001
1	Ulcer 01/2008
1	Soft Tissue Infections 01/2004
1	Sepsis (Septicemia) 01/2002
1	Inflammation (Inflammations) 01/2002
1	Diabetic Foot 01/2001
1	Wound Infection (Wound Infections) 01/2000

Drug/Important Bio-Agent (IBA)

2	PlasticsIBA 01/2008 - 01/2000
1	AnticoagulantsIBA 01/2006
1	Levofloxacin (Levaquin)FDA Link 01/2004
1	GlycopeptidesIBA 01/2004
1	FluoroquinolonesIBA 01/2004
1	Adenosine Triphosphate (ATP)IBA 01/2002
1	AntibodiesIBA 01/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	Superoxides (Superoxide)IBA 01/2002
1	Oxygen (Dioxygen)IBA 01/2001
1	N 30IBA 01/2001
1	Pharmaceutical PreparationsIBA 01/2001
1	Fibrinogen (Factor I)FDA Link 01/2001
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 01/2001
1	ticarcillin-clavulanic acid (Timentin)FDA Link 01/2000
1	Vancomycin FDA LinkGeneric 01/2000
1	Ticarcillin (Tarcil)FDA Link 01/2000
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2000
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 01/2000
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2000

Therapy/Procedure

4	Therapeutics 01/2008 - 01/2000
1	Trephining 01/2008